Correlation Between CytomX Therapeutics and BWV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and BWV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and BWV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and BWV, you can compare the effects of market volatilities on CytomX Therapeutics and BWV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of BWV. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and BWV.

Diversification Opportunities for CytomX Therapeutics and BWV

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between CytomX and BWV is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and BWV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BWV and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with BWV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BWV has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and BWV go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and BWV

Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.62 times more return on investment than BWV. However, CytomX Therapeutics is 1.62 times more volatile than BWV. It trades about 0.03 of its potential returns per unit of risk. BWV is currently generating about 0.04 per unit of risk. If you would invest  145.00  in CytomX Therapeutics on September 14, 2024 and sell it today you would lose (37.00) from holding CytomX Therapeutics or give up 25.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy29.09%
ValuesDaily Returns

CytomX Therapeutics  vs.  BWV

 Performance 
       Timeline  
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, CytomX Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
BWV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BWV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BWV is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

CytomX Therapeutics and BWV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CytomX Therapeutics and BWV

The main advantage of trading using opposite CytomX Therapeutics and BWV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, BWV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BWV will offset losses from the drop in BWV's long position.
The idea behind CytomX Therapeutics and BWV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated